Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Allogeneic Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome

NCT01902082 is registered in ClinicalTrials.gov with Shaoxing Second Hospital as lead sponsor.

NCT NCT01902082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01902082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Allogeneic Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome
Lead sponsor
Shaoxing Second Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2012
Completion date
June 30, 2014
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards